A nurse-led ambulatory care pathway for patients with deep venous thrombosis in an acute teaching hospital

International Journal of Lower Extremity Wounds

Volumn 4, Issue 2, 2005, Pages 93-96

  Deagle, Jennifer ^a   Allen, James ^a   Mani, Raj ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Ambulatory home care; Deep vein thrombosis (DVT); Duplex ultrasonography; Low molecular weight heparin (LMWH)

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN; ANTICOAGULANT AGENT;

AMBULATORY CARE; COMPRESSION THERAPY; CONTRAST RADIOGRAPHY; DEEP VEIN THROMBOSIS; DIAGNOSTIC IMAGING; DRUG SAFETY; ECHOGRAPHY; FETUS DISEASE; HUMAN; NURSE; OUTCOMES RESEARCH; PATIENT CARE; PHLEBOGRAPHY; PRIORITY JOURNAL; RELIABILITY; REVIEW; RISK FACTOR; TEACHING HOSPITAL; TREATMENT OUTCOME; ARTICLE; CLINICAL PATHWAY; DOPPLER ECHOGRAPHY; NURSING; NURSING STAFF; STANDARD; VEIN THROMBOSIS;

AMBULATORY CARE; ANTICOAGULANTS; CRITICAL PATHWAYS; HEPARIN, LOW-MOLECULAR-WEIGHT; HOSPITALS, TEACHING; HUMANS; NURSING STAFF, HOSPITAL; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VENOUS THROMBOSIS;

EID: 23044491981     PISSN: 15347346     EISSN: None     Source Type: Journal    
DOI: 10.1177/1534734605277637     Document Type: Review

References (13)

1. Wells PS, Anderson A, Bormanis J. Value of pretest probability in deep vein thrombosis in clinical management. Lancet 1997;350 (9094):1795-8.
2. Mani R, Regan F, Sheridan J, Batty V. Duplex ultrasound scanning for diagnosing deep vein thrombosis. J Dermatol Surg 1995;21(4):322-6.
3. van Dongen CJJ, van den Belt AGM, Prins MH, Lensing AWA. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. In: Cochrane database of systematic reviews. Issue 4. UK; 2004.
4. Seethram K, Okun N. Low molecular weight heparin versus unfractionated heparin for the treatment of venous thromboembolism in pregnancy. In: Cochrane database of systematic reviews. Issue 3. UK; 2004.
5. Hyers TM, Hull RD, Morris TA, Tapson V. Antithrombotic therapy for venous thromboembolic disease. Chest 2001;119:176S-193S.
6. van Dongen CJ, Mac Gillavry MR, Prins MH. Once versus twice daily LMWH for the initial treatment of venous thromboembolism. In: Cochrane database of systematic reviews. Issue 4. UK; 2004.
7. Datapharm Communications. Avenus. Summary of product characteristics for Clexane (Enoxaparin). Surrey, UK: Datapharm Communications; 2004. Retrieved February 21, 2005, from www. medicines.org.uk
8. Scottish Intercollegiate Guidelines Network (SIGN) Thrombosis prophylaxis. Pregnancy and puerperium. Retrieved April 15, 2005, from www.sign.ac.uk/guidelines/fulltext/62/section9.html
9. van der Heijden JF, Hutten BA, Buller HR, Prins MH. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. In: Cochrane database of systematic reviews. Issue 3. UK; 2004.
10. Ginsberg J. Use of antithrombotic agents during pregnancy. Chest 2004;1191:5-6.
11. Hirsch J. Heparin and low-molecular-weight heparin. Chest 2004;119(1):30-1.
12. Hull RD, Carter CJ, Jay RM, et al. The diagnosis of acute, recurrent, deep-vein thrombosis: a diagnostic challenge. Circulation 1983; 67(4):901-5.
13. Hogg K, Ashton A. Antithrombotic treatment of below knee deep vein thrombosis. Emerg Med J 2003;20:364-5.